An HDAC inhibitor for treating cancer with a modified STK11 activity or expression

MYPI2025000831A0Undetermined Publication Date: 2024-02-05TANGO THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025000831
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-04-14
Filing Date
2023-08-04
Publication Date
2024-02-05

Smart Images

  • Figure PI2025000831_DRAWING_001
    Figure PI2025000831_DRAWING_001
  • Figure PI2025000831_DRAWING_002
    Figure PI2025000831_DRAWING_002
  • Figure PI2025000831_DRAWING_003
    Figure PI2025000831_DRAWING_003
Patent Text Reader

Abstract

The disclosure relates to methods of treating cancers, including cancers having modified STK11 activity or expression, by administering an effective amount of a histone deacetylase (HDAC) inhibitor. [Figure 1A]
Need to check novelty before this filing date? Find Prior Art